1
|
Vetter VM, Drewelies J, Düzel S, Homann J, Meyer-Arndt L, Braun J, Pohrt A, Kendel F, Wagner GG, Thiel A, Bertram L, Regitz-Zagrosek V, Gerstorf D, Demuth I. Change in body weight of older adults before and during the COVID-19 pandemic: longitudinal results from the Berlin Aging Study II. J Nutr Health Aging 2024; 28:100206. [PMID: 38460212 DOI: 10.1016/j.jnha.2024.100206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Revised: 02/17/2024] [Accepted: 02/27/2024] [Indexed: 03/11/2024]
Abstract
OBJECTIVES Change in body weight during the COVID-19 pandemic as an unintended side effect of lockdown measures has been predominantly reported for younger and middle-aged adults. However, information on older adults for which weight loss is known to result in adverse outcomes, is scarce. In this study we describe the body weight change in older adults before, during, and after the COVID-19 lockdown measures and explore putative associated factors with a focus on the period that includes the first six months of the COVID-19 containment measures. DESIGN Prospective cohort study with three follow-up examinations over the course of 10 years. SETTING AND PARTICIPANTS In this study, we analyzed the longitudinal weight change of 472 participants of the Berlin Aging Study II (mean age of 67.5 years at baseline). MEASUREMENTS Body weight was assessed at four time points. Additionally, differences between subgroups characterized by socio-economic, cognitive, and psychosocial variables as well as morbidity burden, biological age markers (epigenetic clocks, telomere length), and frailty were compared. RESULTS On average, women and men lost 0.87% (n = 227) and 0.5% (n = 245) of their body weight per year in the study period covering the first six months of the COVID-19 pandemic. Weight loss among men was particularly pronounced among groups characterized by change in physical activity due to COVID-19 lockdown, low positive affect, premature epigenetic age (7-CpG clock), diagnosed metabolic syndrome, and a more masculine gender score (all variables: p < 0.05, n = 245). CONCLUSION During the COVID-19 pandemic, older participants lost weight with a 2.5-times (women) and 2-times (men) higher rate than what is expected in this age.
Collapse
Affiliation(s)
- Valentin Max Vetter
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Endocrinology and Metabolic Diseases (Including Division of Lipid Metabolism), Biology of Aging Working Group, Augustenburger Platz 1, 13353 Berlin, Germany
| | - Johanna Drewelies
- Lise Meitner Group for Environmental Neuroscience, Max Planck Institute for Human Development, Berlin, Germany; Department of Psychology, Humboldt University Berlin, Berlin, Germany
| | - Sandra Düzel
- Max-Planck Institut Für Bildungsforschung, Germany; Friede Springer Cardiovascular Prevention Center, Charité - Universitätsmedizin Berlin (CBF), Berlin, Germany
| | - Jan Homann
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| | - Lil Meyer-Arndt
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, 13353 Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, NeuroCure Clinical Research Center, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neurology with Experimental Neurology, 10117 Berlin, Germany
| | - Julian Braun
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, 13353 Berlin, Germany
| | - Anne Pohrt
- Department of Medical Biometrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
| | - Friederike Kendel
- Gender in Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Gert G Wagner
- German Socio-Economic Panel Study (SOEP), German Institute for Economic Research (DIW), Berlin, Germany; Center for Lifespan Psychology, Max Planck Institute for Human Development, Berlin, Germany
| | - Andreas Thiel
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, 13353 Berlin, Germany
| | - Lars Bertram
- Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Lübeck, Germany
| | - Vera Regitz-Zagrosek
- Institute for Gender in Medicine, Center for Cardiovascular Research, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; Department of Cardiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland
| | - Denis Gerstorf
- Department of Psychology, Humboldt University Berlin, Berlin, Germany
| | - Ilja Demuth
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Endocrinology and Metabolic Diseases (Including Division of Lipid Metabolism), Biology of Aging Working Group, Augustenburger Platz 1, 13353 Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, 13353 Berlin, Germany.
| |
Collapse
|
2
|
Peña-Bautista C, Álvarez-Sánchez L, Ferrer-Cairols I, García-Vallés L, Baquero M, Cháfer-Pericás C. Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression. J Neurol 2023; 270:4585-4592. [PMID: 37505239 DOI: 10.1007/s00415-023-11899-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Revised: 07/21/2023] [Accepted: 07/23/2023] [Indexed: 07/29/2023]
Abstract
INTRODUCTION Recently, many aspects of daily life have changed due to the COVID-19 pandemic. Patients with Alzheimer Disease (AD) could be more vulnerable to those daily life changes as experts expected. Mainly, the lockdown involved reduced social contact and cognitive stimulation. So, it could affect the AD expression, increasing the patients' disabilities development. OBJECTIVE The aim of this study is to evaluate the effect of COVID-19 lockdown on cognitive impairment progression in early AD patients. METHODOLOGY The participants were patients with mild cognitive impairment due to AD (MCI-AD) from the Neurology Unit (La Fe Hospital), who were neuropsychologically evaluated (cognitive impairment, daily activity tests) twice over 2 years. They were classified into a case group (n = 21), evaluated before and after lockdown condition, and a control group (n = 20), evaluated entirely before the lockdown condition. RESULTS All the participants showed increasing cognitive impairment and functional deterioration over the 2-year period of evaluation (p < 0.05). However, a faster worsening was not observed as a consequence of the COVID-19 pandemic and the lockdown condition. In fact, the statistical significance observed between the two study groups for daily life activities showed that the worsening was even lesser in the group evaluated under the lockdown condition. CONCLUSION Medium-term effects of COVID-19 lockdown could not involve an acceleration of the cognitive decline in MCI-AD patients in a 2-year evaluation period. In addition, the least worsening observed for daily living activities in the case group was probably due to the change in routines. Therefore, the common assumption of cognitive worsening of AD progression due to the lockdown in comparison with normal disease progression was not demonstrated in this study, at least for MCI-AD cases. However, more longitudinal studies are required to evaluate long-term effects in these patients.
Collapse
Affiliation(s)
- Carmen Peña-Bautista
- Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
| | - Lourdes Álvarez-Sánchez
- Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
| | - Inés Ferrer-Cairols
- Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
| | - Lorena García-Vallés
- Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
| | - Miguel Baquero
- Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
- Division of Neurology, Hospital Universitari I Politècnic La Fe, Valencia, Spain
| | - Consuelo Cháfer-Pericás
- Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
| |
Collapse
|
3
|
Liu C, Liu N, Zeng Y, Xiao B, Wang P, Zhou C, Xia Y, Zhao Z, Xiao T, Li H. COVID-19 and sarcopenia-related traits: a bidirectional Mendelian randomization study. Front Endocrinol (Lausanne) 2023; 14:1162936. [PMID: 37234804 PMCID: PMC10206246 DOI: 10.3389/fendo.2023.1162936] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Accepted: 04/27/2023] [Indexed: 05/28/2023] Open
Abstract
Background Emerging evidence suggested that coronavirus disease 2019 (COVID-19) patients were more prone to acute skeletal muscle loss and suffer sequelae, including weakness, arthromyalgia, depression and anxiety. Meanwhile, it was observed that sarcopenia (SP) was associated with susceptibility, hospitalization and severity of COVID-19. However, it is not known whether there is causal relationship between COVID-19 and SP-related traits. Mendelian randomization (MR) was a valid method for inferring causality. Methods Data was extracted from the COVID-19 Host Genetic Initiative and the UK Biobank without sample overlapping. The MR analysis was performed with inverse variance weighted, weighted median, MR-Egger, RAPS and CAUSE, MR-APSS. Sensitivity analysis was conducted with MR-Egger intercept test, Cochran's Q test, MR-PRESSO to eliminate pleiotropy. Results There was insufficient result in the MR-APSS method to support a direct causal relationship after the Bonferroni correction. Most other MR results were also nominally consistent with the MR-APSS result. Conclusions Our study first explored the causal relationship between COVID-19 and SP-related traits, but the result indicated that they may indirectly interact with each other. We highlighted that older people had better absorb enough nutrition and strengthen exercise to directly cope with SP during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Chao Liu
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Ningyuan Liu
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
| | - Yi Zeng
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Bo Xiao
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Pingxiao Wang
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Chuqiao Zhou
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Yu Xia
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Ziyue Zhao
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Tao Xiao
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| | - Hui Li
- Department of Orthopedics, the Second Xiangya Hospital of Central South University, Changsha, China
- Orthopedic Biomedical Materials Engineering Laboratory of Hunan Province, Changsha, China
| |
Collapse
|
4
|
Impact of Daycare Service Interruption during COVID-19 Pandemic on Physical and Mental Functions and Nutrition in Older People with Dementia. Healthcare (Basel) 2022; 10:healthcare10091744. [PMID: 36141355 PMCID: PMC9498727 DOI: 10.3390/healthcare10091744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 09/06/2022] [Accepted: 09/08/2022] [Indexed: 11/18/2022] Open
Abstract
This study evaluated changes of cognitive, physical, and nutritional status before and after the interruption and resumption of daycare services during the COVID-19 pandemic in older dementia people in a daycare center. Comprehensive geriatric assessment data were analyzed before and after the lockdown of daycare center services, including mini-mental state examination, activities of daily living (ADL) scores, mini-nutritional assessment-short forms (MNA-SF), and timed up-and-go (TUG) tests. Among 19 dementia people participating in daycare services, 17 participants were enrolled in the study with, finally, two excluded because of incomplete follow-ups. They had a median age of 81 years; their MNA-SF scores and TUG values deteriorated significantly after a 3-month closure of daycare services (p < 0.05), and after resumption of daycare services the MNA-SF scores and TUG values recovered to near the pre-lockdown levels (p < 0.05). Besides, baseline ADL scores predicted a decline and recovery of TUG and MNA-SF values. Our findings suggest that planning continuous support for older dementia adults is important for daycare facilities during COVID-19 pandemic confinement.
Collapse
|
5
|
Ko HJ, Cho YJ, Kim KK, Kang JH, Kim YS, Haam JH, Hur YI, Choi HI, Lee KR, Park JH, Cho SH, Kim JK, Lee T, Seo MJ, Yoon YS, Seo Y, Nam GE, Kim SH. COVID-19 and related social distancing measures induce significant metabolic complications without prominent weight gain in Korean adults. Front Med (Lausanne) 2022; 9:951793. [PMID: 36160167 PMCID: PMC9490037 DOI: 10.3389/fmed.2022.951793] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Accepted: 08/18/2022] [Indexed: 11/24/2022] Open
Abstract
Background This study using multi-center health examination data from Korean adults was conducted to confirm changes in weight, and their related cardiometabolic parameters, before and after strengthening of social distancing regulations. Methods A retrospective cohort study was conducted using health check-up data from 13 university hospitals. The study period was from January 2018 to July 2020. To examine the effect of systematic social distancing measures, participants who underwent a health check-up (Visit 3) between July 2020 and July 2021 (during full scale social distancing), and had undergone two previous health check-ups (Visits 1 and 2) between January 2018 and June 2020 (before social distancing), were selected. In total, data from 7,875 participants were analyzed. Linear mixed-effect models were used to calculate estimates of anthropometric indices and metabolic markers measured on Visits 2 and 3, compared with measurements from Visit 1. Results There were no significant differences in body weight, body mass index, waist circumference, and body composition on Visit 3 than on Visits 1 and 2. However, the odds of metabolic syndrome and its components, including hypertension, high glucose, diabetes, hypercholesterolemia, hypertriglyceridemia, hyper-non-high-density lipoprotein cholesterolemia, and dyslipidemia were significantly higher on Visit 3 than on Visits 1 and 2. The increase in metabolic complications was marked, particularly in relatively young adults who visited health check-up centers located in the capital area. Conclusion Metabolic syndrome and its components were significantly worse after high level social distancing, although there were no significant increases in anthropometric indices and body fat levels. Healthcare providers need to prevent and manage worsening of metabolic parameters in subpopulations prone to be more sedentary and eat unhealthy food during the COVID-19 pandemic and associated social distancing measures.
Collapse
Affiliation(s)
- Hae-Jin Ko
- Department of Family Medicine, School of Medicine, Kyungpook National University Hospital, Daegu, South Korea
| | - Yoon Jeong Cho
- Department Family Medicine, Daegu Catholic University School of Medicine, Daegu, South Korea
| | - Kyoung-Kon Kim
- Department of Family Medicine, Gachon University College of Medicine, Gachon University Gil Medical Center, Incheon, South Korea
- *Correspondence: Kyoung-Kon Kim
| | - Jee-Hyun Kang
- Department of Family Medicine, Konyang University College of Medicine, Daejeon, South Korea
| | - Young-Sang Kim
- Department of Family Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea
| | - Ji-Hee Haam
- Department of Family Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea
- Chaum Life Center, CHA University, Seoul, South Korea
| | - Yang-Im Hur
- Department of Family Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea
| | - Hye-In Choi
- Department of Family Medicine, School of Medicine, Kyungpook National University Hospital, Daegu, South Korea
| | - Kyu Rae Lee
- Department of Family Medicine, Gachon University College of Medicine, Gachon University Gil Medical Center, Incheon, South Korea
| | - Jung Ha Park
- Department of Family Medicine, Jeju National University Hospital, Jeju, South Korea
| | - Soo Hyun Cho
- Department of Family Medicine, College of Medicine, Chung-Ang University Hospital, Seoul, South Korea
| | - Jong-Koo Kim
- Department of Family Medicine, Yonsei University Wonju College of Medicine, Wonju-si, South Korea
| | - Taesic Lee
- Department of Family Medicine, Yonsei University Wonju College of Medicine, Wonju-si, South Korea
| | - Myung-Jae Seo
- Department of Family Medicine, Yonsei University Wonju College of Medicine, Wonju-si, South Korea
| | - Yeong Sook Yoon
- Department of Family Medicine, Inje University Ilsan Paik Hospital, Goyang-si, South Korea
| | - Yoobin Seo
- Department of Family Medicine, Sanbon Medical Center, School of Medicine, Wonkwang University, Gunpo-si, South Korea
| | - Ga Eun Nam
- Department of Family Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea
| | - Sun Hyun Kim
- Department of Family Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, South Korea
| |
Collapse
|
6
|
Nutrition Risk, Resilience and Effects of a Brief Education Intervention among Community-Dwelling Older Adults during the COVID-19 Pandemic in Alberta, Canada. Nutrients 2022; 14:nu14051110. [PMID: 35268084 PMCID: PMC8912319 DOI: 10.3390/nu14051110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Revised: 03/02/2022] [Accepted: 03/04/2022] [Indexed: 11/16/2022] Open
Abstract
Up to two-thirds of older Canadian adults have high nutrition risk, which predisposes them to frailty, hospitalization and death. The aim of this study was to examine the effect of a brief education intervention on nutrition risk and use of adaptive strategies to promote dietary resilience among community-dwelling older adults living in Alberta, Canada, during the COVID-19 pandemic. The study design was a single-arm intervention trial with pre–post evaluation. Participants (N = 28, age 65+ years) in the study completed a survey online or via telephone. Questions included the Brief Resilience Scale (BRS), SCREEN-14, a brief poverty screen, and a World Health Organization-guided questionnaire regarding awareness and use of nutrition-related services and resources (S and R). A brief educational intervention involved raising participant awareness of available nutrition S and R. Education was offered via email or postal mail with follow-up surveys administered 3 months later. Baseline and follow-up nutrition risk scores, S and R awareness and use were compared using paired t-test. Three-quarters of participants had a high nutrition risk, but very few reported experiencing financial strain or food insecurity. Those at high nutrition risk were more likely to report eating alone, compared to those who scored as low risk. There was a significant increase in awareness of 20 S and R as a result of the educational intervention, but no change in use. The study shows increasing individual knowledge about services and resources in the community is not sufficient to change use of these services or improve nutrition risk.
Collapse
|
7
|
Levy D, Giannini M, Oulehri W, Riou M, Marcot C, Pizzimenti M, Debrut L, Charloux A, Geny B, Meyer A. Long Term Follow-Up of Sarcopenia and Malnutrition after Hospitalization for COVID-19 in Conventional or Intensive Care Units. Nutrients 2022; 14:912. [PMID: 35215562 PMCID: PMC8880495 DOI: 10.3390/nu14040912] [Citation(s) in RCA: 21] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 02/11/2022] [Accepted: 02/16/2022] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND The post-COVID-19 condition, defined as COVID-19-related signs and symptoms lasting at least 2 months and persisting more than 3 months after infection, appears now as a public health issue in terms of frequency and quality of life alterations. Nevertheless, few data are available concerning long term evolution of malnutrition and sarcopenia, which deserve further attention. METHOD Sarcopenia was investigated prospectively, together with weight evolution, at admission and at 3 and 6 months after hospital discharge in 139 COVID-19 patients, using the European Working Group on Sarcopenia in Older People (EWGSOP2) criteria, associating both decreased muscle strength and muscle mass, assessed, respectively, with hand dynamometer and dual-energy X-ray absorptiometry. RESULTS Of the 139 patients, 22 presented with sarcopenia at 3 months; intensive care units (ICU) length of stay was the sole factor associated with sarcopenia after multivariate analysis. Although the entire group did not demonstrate significant weight change, weight decreased significantly in the sarcopenia group (Five and eight patients, showing, respectively, >5 or >10% weight decrease). Interestingly, at 6 months, 16 of the 22 patients recovered from sarcopenia and their weight returned toward baseline values. CONCLUSIONS Sarcopenia and malnutrition are frequently observed in patients hospitalized for COVID-19, even 3 months after infection occurrence, but can largely be reversed at 6 months after discharge. Enhanced patient care is needed in sarcopenic patients, particularly during long stays in an ICU.
Collapse
Affiliation(s)
- Dan Levy
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
- Physiology and Functional Exploration Service, University Hospital of Strasbourg, 67091 Strasbourg, France
| | - Margherita Giannini
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
- Physiology and Functional Exploration Service, University Hospital of Strasbourg, 67091 Strasbourg, France
| | - Walid Oulehri
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
- Department of Anesthesiology and Surgical Critical Care, University Hospital of Strasbourg, 67091 Strasbourg, France
| | - Marianne Riou
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
- Physiology and Functional Exploration Service, University Hospital of Strasbourg, 67091 Strasbourg, France
| | - Christophe Marcot
- Department of Pneumology, University Hospital of Strasbourg, 67091 Strasbourg, France;
| | - Megane Pizzimenti
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
| | - Lea Debrut
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
| | - Anne Charloux
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
- Physiology and Functional Exploration Service, University Hospital of Strasbourg, 67091 Strasbourg, France
| | - Bernard Geny
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
- Physiology and Functional Exploration Service, University Hospital of Strasbourg, 67091 Strasbourg, France
| | - Alain Meyer
- Translational Medicine Federation of Strasbourg (FMTS), Team 3072 “Mitochondria, Oxidative Stress and Muscle Protection”, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; (D.L.); (M.G.); (W.O.); (M.R.); (M.P.); (L.D.); (A.C.); (A.M.)
- Physiology and Functional Exploration Service, University Hospital of Strasbourg, 67091 Strasbourg, France
| |
Collapse
|